Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Differential effects of antihypertensive drugs on central blood pressure: beta-blocker vs ARB
KCT0003528Phase 4Completed
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of carvedilol in hypertension (HTN) (2 arms), sponsored by Ildong Pharmaceutical Co Ltd. Primary endpoint: Central blood pressure change. Started Jan 2019; status: completed.
02
Drugs
carvedilol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on KCT0003528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003528.